Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction

被引：12
|
作者：
Daou, Daniel [1 ]
Gillette, Thomas G. [1 ]
Hill, Joseph A. [1 ,2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX USA
来源：
PHYSIOLOGY | 2023年 / 38卷 / 05期
基金：
美国国家卫生研究院;
关键词：
heart failure; inflammation; meta-inflammation; myocardial remodeling; EPICARDIAL ADIPOSE-TISSUE; TUMOR-NECROSIS-FACTOR; HIGH-DENSITY-LIPOPROTEINS; CLONAL HEMATOPOIESIS; CARDIAC-HYPERTROPHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; MACROPHAGE POLARIZATION; DIASTOLIC DYSFUNCTION;
D O I：
10.1152/physiol.00004.2023
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
Heart failure with preserved ejection fraction (HFpEF) is now the most common form of heart failure and a significant public health concern for which limited effective therapies exist. Inflammation triggered by comorbidity burden is a critical element of HFpEF pathophysiology. Here, we discuss evidence for comorbidity-driven systemic and myocardial inflammation and the mechanistic role of inflammation in pathological myocardial remodeling in HFpEF.
引用
收藏
页码：217 / 230
页数：14
相关论文
共 50 条
  • [1] Immunometabolic mechanisms of heart failure with preserved ejection fraction
    Schiattarella G.G.
    Alcaide P.
    Condorelli G.
    Gillette T.G.
    Heymans S.
    Jones E.A.V.
    Kallikourdis M.
    Lichtman A.
    Marelli-Berg F.
    Shah S.J.
    Thorp E.B.
    Hill J.A.
    Nature Cardiovascular Research, 2022, 1 (3): : 211 - 222
  • [2] Mechanisms of Hyperventilation in Heart Failure with Preserved Ejection Fraction
    Urbina, M. Faria
    Oliveira, R.
    Waxman, A. B.
    Systrom, D. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [3] Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction
    Segar, Matthew W.
    Coulter, Stephanie A.
    TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (05)
  • [4] Primary inflammatory disease in heart failure with preserved ejection fraction
    Tada, A.
    Doi, S.
    Harada, T.
    Ibe, T.
    Jwan, N.
    Amdahl, M.
    Reddy, Y.
    Borlaug, B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [5] Inflammatory pathways in patients with heart failure and preserved ejection fraction
    Niethammer, Margit
    Sieber, Moritz
    von Haehling, Stephan
    Anker, Stefan D.
    Munzel, Thomas
    Horstick, Georg
    Genth-Zotz, Sabine
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 129 (01) : 111 - 117
  • [6] Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
    Borlaug, Barry A.
    CIRCULATION JOURNAL, 2014, 78 (01) : 20 - 32
  • [7] Mechanisms of Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction
    Sarma, Satyam
    Stoller, Douglas
    Hendrix, Joseph
    Howden, Erin
    Lawley, Justin
    Livingston, Sheryl
    Adams-Huet, Beverley
    Holmes, Courtney
    Goldstein, David S.
    Levine, Benjamin D.
    CIRCULATION-HEART FAILURE, 2020, 13 (03) : E006331
  • [8] Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
    Omote, Kazunori
    Verbrugge, Frederik H.
    Borlaug, Barry A.
    ANNUAL REVIEW OF MEDICINE, 2022, 73 : 321 - 337
  • [9] Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management
    Meagher, Patrick
    Adam, Mohamed
    Civitarese, Robert
    Bugyei-Twum, Antoinette
    Connelly, Kim A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (05) : 632 - 643
  • [10] Heart failure with preserved ejection fraction: from mechanisms to therapies
    Lam, Carolyn S. P.
    Voors, Adriaan A.
    de Boer, Rudolf A.
    Solomon, Scott D.
    van Veldhuisen, Dirk J.
    EUROPEAN HEART JOURNAL, 2018, 39 (30) : 2780 - 2792
12345